Actions requested Providers, facilities, parents and children should stop using Diep Bao Baby Skin Cream. Background On Feb. 1, 2023, Shop Me Ca recalled Diep Bao Skin Cream because of possible health risk. Shop Me Ca of Herndon, Virginia recalled its 10-gram tubes of “Diep Bao Cream” because they have the potential to be contaminated … 02/13/23 Health Advisory: Shop Me Ca “Diep Bao Cream” Recalled
Actions requested Background Washington State Department of Health (DOH) and Centers for Disease Control and Prevention (CDC) are investigating a cluster of antibiotic-resistant infections that may be linked to artificial tears. The most frequently reported brand was EzriCare Artificial Tears, a preservative-free product dispensed in muti-dose bottles. These over-the-counter eye drops are sold widely in … 02/03/23 Health Advisory: Multistate Cluster of Antibiotic Resistant Bacteria Associated with Artificial Tears
Earlier this month, U.S. Food and Drug Administration (FDA) and Centers for Disease Control and Prevention (CDC) expanded emergency use authorization (EUA) of Moderna and Pfizer-BioNTech bivalent vaccines for children 6 months and older. Updated (bivalent) COVID-19 booster vaccines are formulated to boost immunity against the original coronavirus strain and protect against the newer omicron … Health Advisory: Updated bivalent COVID-19 boosters authorized for children 6 months to 5 years old
Be advised: Background Seasonal flu activity is high across the United States. Vaccination and antiviral treatment help prevent and control flu. U.S. Food and Drug Administration (FDA) approved 4 antivirals for early treatment of outpatients with flu: oseltamivir, baloxavir, zanamivir and peramivir. While FDA does not report shortages of oseltamivir in any of its forms, providers … 12/19/22 Health Advisory: Antiviral Flu Treatment Interim Guidance
On April 21, 2022, President Biden announced a new Uniting for Ukraine (U4U) process to help Ukrainian citizens fleeing war come to the United States temporarily. As of Nov. 18, 2022: Newly arrived Ukrainian citizens have various medical and mental health needs. Resources
Bebtelovimab no longer authorized in the United States. On Nov. 30, 2022, U.S. Food and Drug Administration (FDA) revoked its Emergency Use Authorization (EUA) for bebtelovimab. Bebtelovimab is a monoclonal antibody used to treat COVID-19. FDA revoked the EUA because the drug lost efficacy against most SARS-CoV-2 variants currently circulating in the United States. Currently, … 12/12/22 Health Advisory: COVID-19 Therapeutics Updates
On Nov. 18, Washington State Department of Health (DOH) issued a high-level alert on a surge in respiratory syncytial virus (RSV) causing remarkable strain on pediatric emergency departments (EDs) and intensive care units (ICUs). This alert followed Centers for Disease Control and Prevention’s (CDC’s) Nov. 4 Health Alert Network (HAN) advisory on multiple viruses causing … 11/22/22 Health Advisory: Pediatric respiratory illness increasing in Western Washington
Multiple viruses are causing increased respiratory illness, especially among children, straining healthcare systems. Transmission of respiratory illnesses is increased in our communities. Schools report much higher absenteeism than normal for this time of year. Our hospital emergency departments are seeing many patients. This increase in illness early in respiratory illness season highlights the importance of … 11/08/22 Health Advisory: Increased Respiratory Virus Activity
Requested actions Vaccine This season’s updates in Centers for Disease Control and Prevention’s (CDC’s) Prevention and Control of Influenza (MMWR Vol. 71/No. 1): Surveillance Seasonal influenza surveillance starts in October and continues through April. We expect SARS-CoV-2 and influenza viruses will circulate simultaneously. To aid testing and treatment decisions, stay aware of local influenza and … 10/27/22 Health Advisory: 2022–2023 Influenza Season Surveillance, Testing & Treatment
Centers for Disease Control and Prevention (CDC), Food and Drug Administration (FDA) and Western States Scientific Safety Review Workgroup approved an age expansion for updated bivalent COVID-19 vaccine booster doses. The expansion allows children: 5–11 years old to get 1 booster dose of Pfizer pediatric updated bivalent COVID-19 vaccine. 6–17 years old to get 1 … 10/19/22 Health Advisory: Updated bivalent COVID-19 boosters available to children 5 years or older
